Latest revenue
—
as of —
Latest net income
—
as of —
Net margin
—
as of —
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $27.0M
- Enterprise value
- $27.0M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $1.02
- 52-wk low
- $0.18
- Beta
- —
- Shares out
- 33.5M
5-year trend
About BFNH
Business description and risk factors will appear here once BFNH's latest filing is fully ingested.
Profitability
Return on equity
56.1%
163.4%Return on assets
-164370.4%
188.9%Leverage
Debt / equity
-1.00×
0.0%Debt / assets
292923.4%
9.7%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | — | — | $-102.4K | +89.0% | — |
Q4 2025 2025-12-31 | — | — | $-118.6K | +3.7% | — |
Q3 2025 2025-09-30 | — | — | $-115.9K | +5.0% | — |
Q2 2025 2025-06-30 | — | — | $-122.8K | -7.3% | — |
Q1 2025 2025-03-31 | — | — | $-934.6K | -614.5% | — |
Q4 2024 2024-12-31 | — | — | $-123.2K | — | — |
Q3 2024 2024-09-30 | — | — | $-122.0K | -7.4% | — |
Q2 2024 2024-06-30 | — | — | $-114.4K | -0.4% | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Laboratory Analytical Instruments · SIC 3826
Your notes
Keep private notes on BFNH — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for BFNH in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns BFNH
No institutional holdings on file for BFNH yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once BFNH's latest filing finishes processing.